title: Isolated intestinal versus composite visceral allografts: causes of graft failure.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: de Vera
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: J
authors.initials: J
authors.lastname: Demetris
authors.forename: G
authors.initials: G
authors.lastname: Mazariegos
authors.forename: N
authors.initials: N
authors.lastname: Schaefer
authors.forename: H
authors.initials: H
authors.lastname: Vargas
authors.forename: G
authors.initials: G
authors.lastname: Bond
authors.forename: T
authors.initials: T
authors.lastname: Wu
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007422:Intestines / Q000637:transplantation*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000453:epidemiology; D011183:Postoperative Complications / Q000145:classification* / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology / Q000379:methods*; D017211:Treatment Failure; D014781:Viscera / Q000637:transplantation*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009173:Mycophenolic Acid; D001379:Azathioprine